Cyclo Therapeutics, Inc.

CYTH · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$20-$15-$14-$9
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0-$0
Stock-Based Comp.$1$1$0$0
Change in WC$3-$0-$1$0
Other Non-Cash$0-$0$0$0
Operating Cash Flow-$16-$15-$15-$9
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0$0$0-$0
Financing Activities
Debt Repay.$0$0-$0$0
Stock Issued$10$0$19$18
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$14$0$0$0
Financing Cash Flow$24$0$19$19
Forex Effect$0$0$0$0
Net Chg. in Cash$8-$15$4$10
Supplemental Information
Beg. Cash$2$17$13$3
End Cash$9$2$17$13
Free Cash Flow-$16-$15-$15-$9
Cyclo Therapeutics, Inc. (CYTH) Financial Statements & Key Stats | AlphaPilot